# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-22-000053
Filing Date
2022-05-03
Accepted
2022-05-03 08:00:21
Documents
16
Period of Report
2022-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesn-20220503.htm iXBRL | 8-K | 44467
2 | EX-99.1 | a20220503strategicaltern.htm | EX-99.1 | 12298
6 |  | a20220503strategicaltern001.jpg | GRAPHIC | 290666
7 |  | a20220503strategicaltern002.jpg | GRAPHIC | 309202
8 |  | a20220503strategicaltern003.jpg | GRAPHIC | 292285
| Complete submission text file | 0001485003-22-000053.txt |  | 1433873

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sesn-20220503.xsd | EX-101.SCH | 1914
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sesn-20220503_lab.xml | EX-101.LAB | 24993
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sesn-20220503_pre.xml | EX-101.PRE | 13190
10 | EXTRACTED XBRL INSTANCE DOCUMENT | sesn-20220503_htm.xml | XML | 11816

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22884662
SIC: 2834 Pharmaceutical Preparations